1 / 4

Pharmacogenomics Market Market help to boost economy

The global pharmacogenomics market is expected to transform conventional one size fits all market to a personalized therapy-based market in the pharmaceutical drug development industry.

newmarketindustry
Télécharger la présentation

Pharmacogenomics Market Market help to boost economy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Pharmacogenomics Market Expected to Reach $10,265.5 Million, by 2025 The global pharmacogenomics market is expected to transform conventional one size fits all market to a personalized therapy-based market in the pharmaceutical drug development industry. Onkar Sumant Research Manager, Healthcare at Allied Market Research Pharmacogenomics Market is projected to reach $10,265.5 million by 2025, growing at a CAGR of 8.61% from 2018 to 2025.

  2. Pharmacogenomics is the field of science that deals with the role of genes in a drug response in an individual. The increase in the number of pharmacogenomics-based tests due to growth in ailments, such as cancer, tuberculosis, Alzheimers disease, cardiovascular diseases, and other mortality causing diseases, is expected to boost the market growth. The market for pharmacogenomics has witnessed tremendous growth in the recent years, owing to rise in patient preference toward personalized therapy-based medications. Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/5220 The major factors that boost the growth of the pharmacogenomics market are technological advancements in molecular diagnostics including several molecular biology techniques such as polymerase chain reaction, sequencing, microarrays, electrophoresis, mass spectrometry among others, surge in the preference for using personalized therapy and rise in adoption of pharmacogenomics procedure. In addition, increase in unmet medical needs in the developing countries and drug recalls and failures are anticipated to offer lucrative opportunities for the market growth. However, dearth of skilled professionals and high costs associated with pharmacogenomics solutions and kits hamper the market growth. However, the unmet medical needs in the developing countries along with rise in disposable incomes of the global population is also anticipated to provide lucrative opportunities for the market during the forecast period. By application, the polymerase chain reaction segment dominated the global pharmacogenomics market, accounting for 41% share of the market in 2017, growing at a CAGR of 8.9% from 2018 to 2025. This is attributed to increase in geriatric population and rise in demand for pharmacogenomics tests for the early detection of cancer. Manufacturers of pharmacogenomics solutions, kits, and services have focused on developing bioinformatics related tools for the analysis and interpretations of the large data after the test to conform the results. Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/5220 The application of pharmacogenomics in oncology has the largest contribution with more than half the market share in 2017. Pharmacogenomic products majorly find applications in hospitals and clinics, research organizations, and research institutes as they are a relatively new modality, has a limitation for an end user owing to the complexities in finding the right drug that is well suited to an individual for a specific disease. All these factors together drive the demand for pharmacogenomics for diagnosis

  3. and screening of diseases. Key Findings of the Pharmacogenomics Market: • Based on application, oncology accounted for approximately 37% share of the market in 2017. • Based on region, North America accounted for more than one-thirds market share in 2017 and is expected to maintain this trend throughout the forecast period. • Based on end user, the hospitals segment is anticipated to grow at a CAGR of 8.4% from 2018 to 2025. • Based on technology, the mass spectrometry segment is estimated to grow at the highest CAGR of 9.3% during the forecast period. Access Full Summery @ https://www.alliedmarketresearch.com/pharmacogenomics-market About us: Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain. Allied Market Research provides a one-stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies the client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligence support to aid the clients to turn into a prominent business firm. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916

  4. India (Pune): +91-20-66346060 Fax: +1⟨855⟩550-5975 help@alliedmarketresearch.com Web: www.alliedmarketresearch.com

More Related